newsfilter
← Latest News
Business Wire·

Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, announced today